| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $5K | -69.4% |
| Operating Income | -$152K | -53.0% |
| Income Tax | $0 | — |
| Net Income | -$82K | +17.5% |
| EPS (Basic) | -$0.00 | +96.0% |
| EPS (Diluted) | -$0.00 | +96.0% |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Current Assets | $0 | -100.0% |
| Total Assets | $0 | -100.0% |
| Current Liabilities | $2.3M | -2.3% |
| Total Liabilities | $2.3M | -2.3% |
| Stockholders' Equity | -$2.3M | +2.3% |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42K | -34.4% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $39K | +27.2% |